αV- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients
- 1 August 2003
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 90 (2), 248-257
- https://doi.org/10.1016/s0090-8258(03)00321-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Detection of Malignant Epithelial Cells in Effusions Using Flow Cytometric ImmunophenotypingAmerican Journal of Clinical Pathology, 2002
- The Role of Desmin and N-Cadherin in Effusion CytologyThe American Journal of Surgical Pathology, 2001
- Expression of Cell Cycle Proteins in Ovarian Carcinoma Cells in Serous Effusions—Biological and Prognostic ImplicationsGynecologic Oncology, 2001
- Expression of Membrane-Type 1, 2, and 3 Matrix Metalloproteinases Messenger RNA in Ovarian Carcinoma Cells in Serous EffusionsAmerican Journal of Clinical Pathology, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- αvβ3 and Vitronectin Expression by Normal Ovarian Surface Epithelial Cells: Role in Cell Adhesion and Cell ProliferationGynecologic Oncology, 1999
- The Role of Integrins in Tumorigenesis and MetastasisCancer Investigation, 1998
- Expression and Localization of αv Integrins and Their Ligand Vitronectin in Normal Ovarian Epithelium and in Ovarian CarcinomaGynecologic Oncology, 1996
- Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradationInternational Journal of Cancer, 1996
- Integrins.JCI Insight, 1991